Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kapur, Arvinder ^a   Felder, Mildred ^a   Fass, Lucas ^a   Kaur, Justanjot ^a   Czarnecki, Austin ^a   Rathi, Kavya ^a   Zeng, San ^b   Osowski, Kathryn Kalady ^c   Howell, Colin ^c   Xiong, May P ^b   Whelan, Rebecca J ^c   Patankar, Manish S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c OBERLIN COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRAL; LACTONE; MACROGOL DERIVATIVE; NANOPARTICLE; POLY(ETHYLENE GLYCOL)-BLOCK-POLY(EPSILON-CAPROLACTONE); PROTEIN P53; REACTIVE OXYGEN METABOLITE; TERPENE; TP53 PROTEIN, HUMAN;

APOPTOSIS; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LACTONES; MONOTERPENES; NANOPARTICLES; OXIDATIVE STRESS; POLYETHYLENE GLYCOLS; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84976502335     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27530     Document Type: Article

References (34)

1. National Toxicology, P. NTP toxicology and carcinogenesiss studies of citral (microencapsulated) (CAS No. 5392-40-5) in F344/N rats and B6C3F1 mice (feed studies). National Toxicology Program technical report series, 1-268 (2003).
2. Ress, N. B. et al. Toxicology and carcinogenesis studies of microencapsulated citral in rats and mice. Toxicological sciences: an ofcial journal of the Society of Toxicology 71, 198-206 (2003).
3. Dudai, N., Weinstein, Y., Krup, M., Rabinski, T. & Ofr, R. Citral is a new inducer of caspase-3 in tumor cell lines. Planta Med 71, 484-488, doi: 10.1055/s-2005-864146 (2005).
4. Xia, H. et al. The in vitro study of apoptosis in NB4 cell induced by citral. Cytotechnology 65, 49-57, doi: 10.1007/s10616-012-9453-2 (2013).
5. Connor, M. J. Modulation of tumor promotion in mouse skin by the food additive citral (3, 7-dimethyl-2, 6-octadienal). Cancer letters 56, 25-28 (1991).
6. Liu, Y. et al. Terpenoids from Zingiber ofcinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53. PloS one 7, e53178, doi: 10.1371/journal.pone.0053178 (2012).
7. Zheng, S., Kapur, A., Patankar, M. S. & Xiong, M. Formulation, Characterization, and Antitumor Properties of Trans-and Cis-Citral in the 4T1 Breast Cancer Xenograf Mouse Model. Pharmaceutical research 32, 2548-2558, doi: 10.1007/s11095-015-1643-0 (2015).
8. Yang, N., Mosher, R., Seo, S., Beebe, D. & Friedl, A. Syndecan-1 in breast cancer stroma fbroblasts regulates extracellular matrix fber organization and carcinoma cell motility. The American journal of pathology 178, 325-335, doi: 10.1016/j.ajpath.2010.11.039 (2011).
9. Burrows, J. A., Willis, L. K. & Perlmutter, D. H. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT defciency. Proc Natl Acad Sci USA 97, 1796-1801 (2000).
10. Rubenstein, R. C. & Zeitlin, P. L. Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafcking of DeltaF508-CFTR. American journal of physiology. Cell physiology 278, C259-267 (2000).
11. Perlmutter, D. H. Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafcking. Pediatric research 52, 832-836, doi: 10.1203/00006450-200212000-00004 (2002).
12. Miyashita, T. et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805 (1994).
13. Miyashita, T. & Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
14. Pijnenborg, J. M., Wijnakker, M., Hagelstein, J., Delvoux, B. & Groothuis, P. G. Hypoxia contributes to development of recurrent endometrial carcinoma. International journal of gynecological cancer: ofcial journal of the International Gynecological Cancer Society 17, 897-904, doi: 10.1111/j.1525-1438.2007.00893.x (2007).
15. Wu, H. M. et al. Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKCdelta-mediated activation of p53/p21. Cancer letters 298, 16-25, doi: 10.1016/j.canlet.2010.05.022 (2010).
16. Yaginuma, Y. & Westphal, H. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res 52, 4196-4199 (1992).
17. Korch, C. et al. DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecol Oncol 127, 241-248.
18. Komarov, P. G. et al. A chemical inhibitor of p53 that protects mice from the side efects of cancer therapy. Science 285, 1733-1737 (1999).
19. Nakamura, Y. et al. A phase II detoxification enzyme inducer from lemongrass: identification of citral and involvement of electrophilic reaction in the enzyme induction. Biochem Biophys Res Commun 302, 593-600 (2003).
20. Esterbauer, H., Zollner, H. & Scholz, N. Reaction of glutathione with conjugated carbonyls. Zeitschrif fur Naturforschung. Section C: Biosciences 30, 466-473 (1975).
21. Griffith, O. W. & Meister, A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 254, 7558-7560 (1979).
22. Osato, S. et al. On the inhibiting efect of citral and some other aldehydes on Yoshida rat sarcoma. Gann =Gan 41, 161-165 (1950).
23. Osato, S., Oda, K. & Hanno, A. Experimental chemotherapy of cancer in rat with citral-combinations. Gan. Gann; the Japanese journal of cancer research 44, 348-349 (1953).
24. Chaouki, W., Leger, D. Y., Liagre, B., Beneytout, J. L. & Hmamouchi, M. Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells. Fundamental & clinical pharmacology 23, 549-556, doi: 10.1111/j.1472-8206.2009.00738.x (2009).
25. Farah, I. O., Trimble, Q., Ndebele, K. & Mawson, A. Retinoids and citral modulated cell viability, metabolic stability, cell cycle progression and distribution in the a549 lung carcinoma cell line-biomed 2010. Biomedical sciences instrumentation 46, 410-421 (2010).
26. Diliberto, J. J. et al. Metabolism of citral, an alpha, beta-unsaturated aldehyde, in male F344 rats. Drug metabolism and disposition: the biological fate of chemicals 18, 866-875 (1990).
27. Arrick, B. A. & Nathan, C. F. Glutathione metabolism as a determinant of therapeutic efcacy: a review. Cancer Res 44, 4224-4232 (1984).
28. Iersel, M. L. et al. Inhibition of glutathione S-transferase activity in human melanoma cells by alpha, beta-unsaturated carbonyl derivatives. Efects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal. Chem Biol Interact 102, 117-132 (1996).
29. Chen, C. Y. et al. 6-shogaol (alkanone from ginger) induces apoptotic cell death of human hepatoma p53 mutant Mahlavu subline via an oxidative stress-mediated caspase-dependent mechanism. J Agric Food Chem 55, 948-954, doi: 10.1021/jf0624594 (2007).
30. Wu, H. et al. 6-Shogaol is more efective than 6-gingerol and curcumin in inhibiting 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice. Mol Nutr Food Res 54, 1296-1306 (2010).
31. Zeng, S. & Xiong, M. P. Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1). Biomaterials 34, 6882-6892, doi: 10.1016/j.biomaterials.2013.05.010 (2013).
32. Forrest, M. L., Won, C. Y., Malick, A. W. & Kwon, G. S. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Journal of controlled release: official journal of the Controlled Release Society 110, 370-377, doi: 10.1016/j.jconrel.2005.10.008 (2006).
33. Spinner, D. M. MTT growth assays in ovarian cancer. Methods Mol Med 39, 175-177 (2001).
34. Denizot, F. & Lang, R. Rapid colorimetric assay for cell growth and survival. Modifcations to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89, 271-277 (1986).